Français
ItalianoBond Gilead Sciences 3.5% ( US375558AZ68 ) in USD
| Issuer | Gilead Sciences | ||||||
| Market price | 97.34 % ▲ | ||||||
| Country |  United States
|
||||||
| ISIN code |
 US375558AZ68 ( in USD )
|
||||||
| Interest rate | 3.5% per year ( payment 2 times a year) | ||||||
| Maturity | 01/02/2025 - Bond has expired | ||||||
|
Prospectus brochure in PDF format |
|||||||
| Minimal amount | 2 000 USD | ||||||
| Total amount | 1 750 000 000 USD | ||||||
| Cusip | 375558AZ6 | ||||||
| Standard & Poor's ( S&P ) rating | BBB+ ( Lower medium grade - Investment-grade ) | ||||||
| Moody's rating | A3 ( Upper medium grade - Investment-grade ) | ||||||
| Detailed description |
Gilead Sciences is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapeutics in areas of unmet medical need, primarily in HIV/AIDS, viral hepatitis, and oncology. Gilead Sciences' US$1,750,000,000 3.5% bonds (CUSIP: 375558AZ6, ISIN: US375558AZ68), maturing February 1, 2025, currently trade at 100% of par value, paying semi-annual interest, with a minimum purchase size of 2,000 bonds, and are rated BBB+ by S&P and A3 by Moody's. |
||||||
| |||||||